Related Experiment Video
Updated: Mar 23, 2026

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
Smurf1 regulation of DAB2IP controls cell proliferation and migration
Xiaoning Li1,2, Xiangpeng Dai2, Lixin Wan2
1Department of Pathophysiology, Basic Medical College, Jilin University, Changchun 130021, China.
Abstract:
Tumor cell proliferation, survival and migration are regulated by the deletion of ovarian carcinoma 2/disabled homolog 2 (DOC-2/DAB2) interacting protein (DAB2IP), a tumor suppressor that serves as a scaffold protein for H-Ras and TRAF2. Importantly, the oncogenic histone methyl-transferase EZH2 epigenetically down-regulates DAB2IP in a variety of tumors. Recently, we demonstrated that DAB2IP is negatively regulated by Akt-dependent phosphorylation and SCFFbw7-mediated degradation. Here, we further identify the oncoprotein Smurf1, an E3-ubiquitin ligase, as a novel negative regulator of DAB2IP. Smurf1-mediated cellular proliferation and migration are largely dependent on the presence of DAB2IP, suggesting that DAB2IP is a key effector molecule of Smurf1 oncogenic function. Additionally, we identify that similar to DAB2IP, Smurf1 is also a target of phosphorylation by both Akt1 and Akt2 kinases, which enhances Smurf1 abundance, leading to a reduction in DAB2IP. Given the role of DAB2IP in tumorigenesis and metastasis, our data identify Smurf1 as an upstream oncogenic factor that negatively regulates DAB2IP to govern aberrant cell growth and migration.
Insights
The oncoprotein Smurf1 negatively regulates the tumor suppressor DAB2IP, promoting cancer cell growth and migration. Akt kinases enhance Smurf1 activity, further reducing DAB2IP levels in tumors.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor cell proliferation, survival, and migration are critical processes regulated by the tumor suppressor ovarian carcinoma 2/disabled homolog 2 (DOC-2/DAB2) interacting protein (DAB2IP).
- DAB2IP acts as a scaffold protein for H-Ras and TRAF2 and is epigenetically downregulated by EZH2 in various cancers.
- Previous research indicated that DAB2IP is negatively regulated by Akt-dependent phosphorylation and SCFFbw7-mediated degradation.
Purpose of the Study:
- To identify novel regulators of DAB2IP.
- To elucidate the role of Smurf1 in regulating DAB2IP and its impact on cancer progression.
- To investigate the interplay between Akt kinases, Smurf1, and DAB2IP in tumorigenesis.
Main Methods:
- Investigated the interaction between Smurf1 and DAB2IP.
- Utilized cell-based assays to assess the impact of Smurf1 on cellular proliferation and migration.
- Examined the role of Akt kinases in phosphorylating and regulating Smurf1 abundance.
- Analyzed the effect of Smurf1 on DAB2IP levels in cancer cells.
Main Results:
- Identified the oncoprotein Smurf1, an E3-ubiquitin ligase, as a novel negative regulator of DAB2IP.
- Demonstrated that Smurf1-mediated cellular proliferation and migration are dependent on DAB2IP, positioning DAB2IP as a key effector of Smurf1's oncogenic function.
- Showed that Akt1 and Akt2 kinases phosphorylate Smurf1, enhancing its abundance and consequently reducing DAB2IP levels.
- Confirmed that Smurf1 negatively regulates DAB2IP, contributing to aberrant cell growth and migration.
Conclusions:
- Smurf1 is a novel upstream oncogenic factor that negatively regulates the tumor suppressor DAB2IP.
- The Akt-Smurf1-DAB2IP axis plays a significant role in governing aberrant cell growth and migration in cancer.
- Targeting Smurf1 may represent a therapeutic strategy for cancers where DAB2IP is downregulated.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Cells Coordinate Growth and Proliferation
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
TGF - β Signaling Pathway

